We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Revolutionizing Surgery with Real-Time Metabolic Profiling

By MedImaging International staff writers
Posted on 27 Jan 2011
Print article
Image: The NMR machine will rapidly analyze intact tissue samples from surgery patients (photo courtesy of Imperial College London).
Image: The NMR machine will rapidly analyze intact tissue samples from surgery patients (photo courtesy of Imperial College London).
Surgical metabonomics, the metabolic profiling of tissue samples, could transform the way surgeons make decisions in the operating theatre.

Researchers at the Imperial College London (ICL; London, United Kingdom) Surgical Metabonomics Laboratory (SML) are using a high-resolution solid-state nuclear magnetic resonance (NMR) spectrometer to analyze intact tissue samples, without preparation. Surgeons will be able to take tissue samples and have them loaded straight into the NMR machine, receiving a readily interpretable readout from the analysis within 20 minutes, which would provide information such as whether the tissues is infected or how good its blood supply is. Surgeons might also use the technology to determine exactly which areas of tissue are cancerous.

"This is a radical change of approach that doesn't just apply to surgery. We want to be able to provide a metabolic map of the entire patient journey. Before surgery, metabonomics could tell the doctor how risky surgery might be for that patient, or how best to prepare him for surgery,” said Prof. Jeremy Nicholson, PhD, a leading researcher in biomolecular medicine and head of the department of surgery and cancer, who will lead the SML together with surgical innovator Prof. Lord Ara Darzi, MD. "After the operation, metabonomics might help the doctor to monitor the patient's recovery and prescribe the most suitable drugs or diet. Ultimately we hope to apply this approach to every area of medicine.”

"People respond differently to the physical trauma of surgery, but currently the tools we have to measure how they respond are very limited,” added Lord Darzi. "Blood tests are slow and they can only measure one chemical component at a time; the doctor simply looks at whether a particular measure has gone up or down. Using NMR, we can simultaneously measure all of the chemicals that the body is producing, and analyze those data to give the surgeon real-time information about the patient's condition, which will help him make decisions.”

The science of metabonomics involves comprehensively measuring the metabolic changes in a person's body, using techniques from analytical chemistry that allow researchers to measure simultaneously all of the chemicals produced by the body's metabolism. With knowledge of which molecules correspond to which conditions in the body, this "metabolic fingerprint” can provide a wealth of information about the state of a person's health. Metabonomics has previously been applied to samples of bodily fluids (such as blood and urine) to look for indicators of disease or of how a person might respond to a particular drug.

Related Links:
Imperial College London


Ultrasonic Pocket Doppler
SD1
New
Medical Radiographic X-Ray Machine
TR30N HF
Digital X-Ray Detector Panel
Acuity G4
Ultrasound Imaging System
P12 Elite

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.